Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2023
Adagrasib in Advanced Solid Tumors Harboring a <i>KRAS</i><sup></sup> Mutation
Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, et al.
Clinical Lung Cancer
|
October 4, 2018
Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
Elena Helman, Minh Nguyen, Chris A Karlovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group
Alexander I Spira, Mark D Stewart, Suzanne Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Edward B Garon, Alexander I Spira, Melissa Johnson, et al.
Nature Medicine
|
October 1, 1996
Progesterone implants enhance SIV vaginal transmission and early virus load
P A Marx, A I Spira, A Gettie, et al.
British Journal of Cancer
|
June 25, 2019
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
Daniel Morgensztern, Michal Rose, Saiama N Waqar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2020
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Amer M Zeidan, Maya Ridinger, Tara L Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2023
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases
Marcelo V Negrao, Alexander I Spira, Rebecca S Heist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Detection of NRG1 Gene Fusions in Solid Tumors
Sushma Jonna, Rebecca A Feldman, Jeffrey Swensen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2023
Adagrasib in Advanced Solid Tumors Harboring a <i>KRAS</i><sup></sup> Mutation
Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, et al.
Clinical Lung Cancer
|
October 4, 2018
Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
Elena Helman, Minh Nguyen, Chris A Karlovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group
Alexander I Spira, Mark D Stewart, Suzanne Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2021
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Edward B Garon, Alexander I Spira, Melissa Johnson, et al.
Nature Medicine
|
October 1, 1996
Progesterone implants enhance SIV vaginal transmission and early virus load
P A Marx, A I Spira, A Gettie, et al.
British Journal of Cancer
|
June 25, 2019
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
Daniel Morgensztern, Michal Rose, Saiama N Waqar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2020
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Amer M Zeidan, Maya Ridinger, Tara L Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2023
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With <i>KRAS</i>-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases
Marcelo V Negrao, Alexander I Spira, Rebecca S Heist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2019
Detection of NRG1 Gene Fusions in Solid Tumors
Sushma Jonna, Rebecca A Feldman, Jeffrey Swensen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 11, 2021
A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Ruth Plummer, Emma Dean, Hendrik-Tobias Arkenau, et al.
Page
of 10